Michelle Le Beau, PhD, director of the University of Chicago Medicine Comprehensive Cancer Center, was named to the executive committee of the American Society of Hematology, the group announced.
“I am honored to be elected to the ASH Executive Committee, and to represent its membership at this critical juncture, characterized by the convergence of challenges in funding for research, and dazzling promise in medicine for the treatment of blood disorders, including hematological malignancies,” said Le Beau, the Arthur and Marian Edelstein Professor of Medicine.
Le Beau will serve a four-year term as councillor, the name given to members of the society’s governing body. She has been the director of the UCCCC since 2004.
“This is an exciting yet challenging time for the field,” said 2013 ASH President Janis L. Abkowitz, MD, of the University of Washington, in a statement. “While we are poised to make great discoveries, we are also faced with the continual threat of decreased federal research funding and significant changes in the health-care system that allows us to deliver care to our patients.
Abkowitz said the organization will need strong visionaries, such as Le Beau, to navigate difficult times ahead.